Charles Schwab’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-26,155
| Closed | -$222K | – | 3507 |
|
|
2024
Q2 | $222K | Sell |
26,155
-4,299
| -14% | -$36.5K | ﹤0.01% | 3426 |
|
|
2024
Q1 | $528K | Buy |
30,454
+648
| +2% | +$11.2K | ﹤0.01% | 3005 |
|
|
2023
Q4 | $382K | Sell |
29,806
-1,936
| -6% | -$24.8K | ﹤0.01% | 3169 |
|
|
2023
Q3 | $1.17M | Buy |
31,742
+3,741
| +13% | +$138K | ﹤0.01% | 2749 |
|
|
2023
Q2 | $1.13M | Buy |
28,001
+1,598
| +6% | +$64.3K | ﹤0.01% | 2724 |
|
|
2023
Q1 | $1.91M | Sell |
26,403
-1,916
| -7% | -$139K | ﹤0.01% | 2537 |
|
|
2022
Q4 | $2.32M | Buy |
28,319
+898
| +3% | +$73.6K | ﹤0.01% | 2523 |
|
|
2022
Q3 | $2.59M | Buy |
27,421
+699
| +3% | +$66.1K | ﹤0.01% | 2507 |
|
|
2022
Q2 | $5.21M | Buy |
26,722
+1,047
| +4% | +$204K | ﹤0.01% | 2172 |
|
|
2022
Q1 | $5.96M | Buy |
25,675
+1,017
| +4% | +$236K | ﹤0.01% | 2194 |
|
|
2021
Q4 | $9.72M | Buy |
24,658
+1,277
| +5% | +$503K | ﹤0.01% | 2017 |
|
|
2021
Q3 | $10.5M | Buy |
23,381
+177
| +0.8% | +$79.2K | ﹤0.01% | 1980 |
|
|
2021
Q2 | $9.02M | Buy |
23,204
+589
| +3% | +$229K | ﹤0.01% | 2059 |
|
|
2021
Q1 | $8.12M | Buy |
22,615
+2,280
| +11% | +$819K | ﹤0.01% | 2065 |
|
|
2020
Q4 | $9.98M | Buy |
20,335
+1,042
| +5% | +$511K | ﹤0.01% | 1869 |
|
|
2020
Q3 | $6.25M | Buy |
19,293
+3,620
| +23% | +$1.17M | ﹤0.01% | 1963 |
|
|
2020
Q2 | $5.71M | Buy |
15,673
+1,606
| +11% | +$585K | ﹤0.01% | 1963 |
|
|
2020
Q1 | $2.99M | Buy |
14,067
+791
| +6% | +$168K | ﹤0.01% | 2086 |
|
|
2019
Q4 | $5.47M | Buy |
13,276
+327
| +3% | +$135K | ﹤0.01% | 1973 |
|
|
2019
Q3 | $4.57M | Buy |
12,949
+2,284
| +21% | +$806K | ﹤0.01% | 2009 |
|
|
2019
Q2 | $5.36M | Buy |
10,665
+470
| +5% | +$236K | ﹤0.01% | 1939 |
|
|
2019
Q1 | $10.1M | Buy |
10,195
+553
| +6% | +$550K | 0.01% | 1576 |
|
|
2018
Q4 | $8.38M | Sell |
9,642
-40
| -0.4% | -$34.7K | 0.01% | 1567 |
|
|
2018
Q3 | $10M | Buy |
9,682
+708
| +8% | +$732K | 0.01% | 1641 |
|
|
2018
Q2 | $8.25M | Buy |
8,974
+1,339
| +18% | +$1.23M | 0.01% | 1720 |
|
|
2018
Q1 | $7.45M | Buy |
7,635
+3,451
| +82% | +$3.37M | 0.01% | 1701 |
|
|
2017
Q4 | $1.89M | Buy |
4,184
+719
| +21% | +$325K | ﹤0.01% | 2327 |
|
|
2017
Q3 | $1.43M | Sell |
3,465
-254
| -7% | -$105K | ﹤0.01% | 2405 |
|
|
2017
Q2 | $1.3M | Buy |
3,719
+536
| +17% | +$188K | ﹤0.01% | 2372 |
|
|
2017
Q1 | $1.64M | Buy |
3,183
+178
| +6% | +$91.5K | ﹤0.01% | 2267 |
|
|
2016
Q4 | $1.07M | Buy |
3,005
+160
| +6% | +$56.8K | ﹤0.01% | 2406 |
|
|
2016
Q3 | $1.52M | Buy |
2,845
+193
| +7% | +$103K | ﹤0.01% | 2260 |
|
|
2016
Q2 | $1.49M | Buy |
2,652
+521
| +24% | +$293K | ﹤0.01% | 2195 |
|
|
2016
Q1 | $1.01M | Buy |
2,131
+46
| +2% | +$21.9K | ﹤0.01% | 2340 |
|
|
2015
Q4 | $1.38M | Buy |
2,085
+64
| +3% | +$42.3K | ﹤0.01% | 2248 |
|
|
2015
Q3 | $1.59M | Buy |
2,021
+789
| +64% | +$620K | ﹤0.01% | 2196 |
|
|
2015
Q2 | $1.63M | Buy |
1,232
+391
| +46% | +$516K | ﹤0.01% | 2192 |
|
|
2015
Q1 | $874K | Buy |
841
+340
| +68% | +$353K | ﹤0.01% | 2417 |
|
|
2014
Q4 | $335K | Buy |
+501
| New | +$335K | ﹤0.01% | 2795 |
|